{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:18:46Z","timestamp":1786119526046,"version":"build-2736575974"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>Advancements in medicine and surgery have led to an increasing number of women with valvular heart disease (VHD) reaching reproductive age and pursuing pregnancy. VHD, which may be congenital or acquired, accounts for a significant proportion of heart diseases in pregnant women, with rheumatic heart disease being the predominant cause globally, especially in developing countries. Pregnancy-induced hemodynamic changes can exacerbate preexisting valvular conditions, leading to complications such as heart failure, arrhythmia, and adverse fetal outcomes. Management of pregnant women with VHD requires a comprehensive, multidisciplinary approach involving preconceptional counseling, risk stratification, and careful monitoring throughout pregnancy. Risk assessment models, including CARPREG II, ZAHARA II, mWHO, and the DEVI score, help identify high-risk patients and guide management strategies. Specific challenges arise in patients with mechanical prosthetic valves due to the need for anticoagulation therapy, which must be carefully managed to minimize risks to both mother and fetus. The delivery plan should be tailored to the severity of the valvular disease, with careful consideration of the mode of delivery and the need for anticoagulation management during labor and postpartum. Preconception counseling is crucial in informing women of the potential risks and helping guide family planning decisions. This paper highlights the importance of early diagnosis, tailored treatment, and a multidisciplinary approach to reduce maternal and fetal morbidity and mortality in pregnant women with valvular heart disease.<\/jats:p>","DOI":"10.1097\/crd.0000000000000905","type":"journal-article","created":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T17:16:00Z","timestamp":1742836560000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Management of Valvular Heart Disease in Pregnancy: Challenges, Risk Stratification, and Multidisciplinary Approaches"],"prefix":"10.1097","author":[{"given":"Jatin","family":"Thukral","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, New York Medical College\/Landmark Medical Center, Woonsocket, RI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darshilkumar","family":"Maheta","sequence":"additional","affiliation":[{"name":"Department of Public Health, New York Medical College, Valhalla, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sehajnoor Kaur","family":"Khangurra","sequence":"additional","affiliation":[{"name":"Gian Sagar Medical College, Ramnagar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharth Pravin","family":"Agrawal","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, New York Medical College\/Landmark Medical Center, Woonsocket, RI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harbir","family":"Kaur","sequence":"additional","affiliation":[{"name":"Hamilton Medical Center, Dalton, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Thukral","sequence":"additional","affiliation":[{"name":"Pt. Deendayal Upadhyay National Institute for Persons with Physical Disabilities, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Frishman","sequence":"additional","affiliation":[{"name":"Department of Medicine, New York Medical College, Valhalla, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilbert S.","family":"Aronow","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Westchester Medical Center and New York Medical College, Valhalla, NY"},{"name":"Department of Medicine, Westchester Medical Center and New York Medical College, Valhalla, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,3,24]]},"reference":[{"key":"R1-20250324","doi-asserted-by":"crossref","first-page":"e000712","DOI":"10.1161\/JAHA.113.000712","article-title":"Pregnancy complicated by valvular heart disease: an update.","volume":"3","author":"Nanna","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"R2-20250324","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1093\/eurheartj\/ehz136","article-title":"Pregnancy outcomes in women with cardiovascular disease: evolving trends over 10 years in the ESC Registry Of Pregnancy And Cardiac disease (ROPAC).","volume":"40","author":"Roos-Hesselink","year":"2019","journal-title":"Eur Heart J"},{"key":"R3-20250324","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1161\/CIRCRESAHA.121.319895","article-title":"Pregnancy and reproductive risk factors for cardiovascular disease in women.","volume":"130","author":"O\u2019Kelly","year":"2022","journal-title":"Circ Res"},{"key":"R4-20250324","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1016\/j.jacc.2018.02.076","article-title":"Pregnancy outcomes in women with heart disease: the CARPREG II study.","volume":"71","author":"Silversides","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R5-20250324","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1161\/hc3001.093437","article-title":"Prospective multicenter study of pregnancy outcomes in women with heart disease.","volume":"104","author":"Siu","year":"2001","journal-title":"Circulation"},{"key":"R6-20250324","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0735-1097(00)01198-0","article-title":"The effect of valvular heart disease on maternal and fetal outcome of pregnancy.","volume":"37","author":"Hameed","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"R7-20250324","doi-asserted-by":"crossref","first-page":"111","DOI":"10.5830\/CVJA-2016-052","article-title":"Valvular heart disease in pregnancy.","volume":"27","author":"Anthony","year":"2016","journal-title":"Cardiovasc J Afr"},{"key":"R8-20250324","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0029-7844(96)00069-5","article-title":"A longitudinal study of maternal hemodynamics during normal pregnancy.","volume":"88","author":"Vanoppen","year":"1996","journal-title":"Obstet Gynecol"},{"key":"R9-20250324","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jacc.2005.02.085","article-title":"Valvular heart disease and pregnancy: part I: native valves.","volume":"46","author":"Elkayam","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R10-20250324","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1161\/CIRCULATIONAHA.114.009029","article-title":"Cardiovascular physiology of pregnancy.","volume":"130","author":"Sanghavi","year":"2014","journal-title":"Circulation"},{"key":"R11-20250324","doi-asserted-by":"crossref","first-page":"13","DOI":"10.14797\/mdcvj.1323","article-title":"Valvular heart disease in pregnancy.","volume":"20","author":"Shapiro","year":"2024","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"R12-20250324","first-page":"H1060","article-title":"Serial study of factors influencing changes in cardiac output during human pregnancy.","volume":"256","author":"Robson","year":"1989","journal-title":"Am J Physiol"},{"key":"R13-20250324","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJMoa1311485","article-title":"Risk of a thrombotic event after the 6-week postpartum period.","volume":"370","author":"Kamel","year":"2014","journal-title":"N Engl J Med"},{"key":"R14-20250324","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1016\/j.jacc.2014.02.536","article-title":"2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines [published correction appears in J Am Coll Cardiol. 2014 Jun 10;63(22):2489. Dosage error in article text].","volume":"63","author":"Nishimura","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R15-20250324","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1093\/eurheartj\/ehq200","article-title":"Predictors of pregnancy complications in women with congenital heart disease.","volume":"31","author":"Drenthen","year":"2010","journal-title":"Eur Heart J"},{"key":"R16-20250324","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1136\/hrt.2006.095240","article-title":"Risks of contraception and pregnancy in heart disease.","volume":"92","author":"Thorne","year":"2006","journal-title":"Heart"},{"key":"R17-20250324","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.jacc.2023.07.023","article-title":"Validation of risk stratification for cardiac events in pregnant women with valvular heart disease.","volume":"82","author":"Pande","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"R18-20250324","doi-asserted-by":"crossref","first-page":"e009018","DOI":"10.1161\/CIRCHEARTFAILURE.121.009018","article-title":"Trending cardiac biomarkers during pregnancy in women with cardiovascular disease.","volume":"15","author":"Chang","year":"2022","journal-title":"Circ Heart Failure"},{"key":"R19-20250324","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/eurheartj\/ehv050","article-title":"Management of valvular disease in pregnancy: a global perspective.","volume":"36","author":"Sliwa","year":"2015","journal-title":"Eur Heart J"},{"key":"R20-20250324","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/clc.4960140409","article-title":"Noninvasive detection of the morphologic and hemodynamic changes during normal pregnancy.","volume":"14","author":"Vered","year":"1991","journal-title":"Clin Cardiol"},{"key":"R21-20250324","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.jacc.2016.06.076","article-title":"Anticoagulation during pregnancy.","volume":"68","author":"Alshawabkeh","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R22-20250324","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jacc.2005.02.087","article-title":"Valvular heart disease and pregnancy.","volume":"46","author":"Elkayam","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R23-20250324","doi-asserted-by":"crossref","first-page":"1248.e1","DOI":"10.1016\/j.cjca.2015.11.005","article-title":"Anticoagulation regimens during pregnancy in patients with mechanical heart valves: a systematic review and meta-analysis.","volume":"32","author":"Xu","year":"2016","journal-title":"Can J Cardiol"},{"key":"R24-20250324","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1177\/1076029610371470","article-title":"A prospective trial showing the safety of adjusted-dose enoxaparin for thromboprophylaxis of pregnant women with mechanical prosthetic heart valves.","volume":"17","author":"Saeed","year":"2010","journal-title":"Clin Appl Thromb Hemost"},{"key":"R25-20250324","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1586\/14779072.2015.1107476","article-title":"Antiarrhythmic drugs in pregnancy.","volume":"13","author":"Wright","year":"2015","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"R26-20250324","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s12471-011-0077-5","article-title":"Electrical cardioversion during pregnancy: safe or not?","volume":"19","author":"Tromp","year":"2011","journal-title":"Neth Heart J"},{"key":"R27-20250324","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"R28-20250324","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1161\/CIRCULATIONAHA.111.030601","article-title":"Management of severe mitral stenosis during pregnancy.","volume":"124","author":"Norrad","year":"2011","journal-title":"Circulation"},{"key":"R29-20250324","doi-asserted-by":"crossref","first-page":"e691S","DOI":"10.1378\/chest.11-2300","article-title":"VTE, thrombophilia, antithrombotic therapy, and pregnancy.","volume":"141","author":"Bates","year":"2012","journal-title":"Chest"},{"key":"R30-20250324","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4103\/0970-9185.168169","article-title":"Combined mitral and aortic stenosis in parturient: anesthesia management for labor and delivery.","volume":"33","author":"Kela","year":"2017","journal-title":"J Anaesthesiol Clin Pharmacol"},{"key":"R31-20250324","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0002-9343(80)90181-3","article-title":"Maternal and fetal sequelae of anticoagulation during pregnancy.","volume":"68","author":"Hall","year":"1980","journal-title":"Am J Med"},{"key":"R32-20250324","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1161\/CIRCULATIONAHA.106.183095","article-title":"Prevention of infective endocarditis.","volume":"116","author":"Wilson","year":"2007","journal-title":"Circulation"},{"key":"R33-20250324","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1016\/j.jacc.2008.10.001","article-title":"ACC\/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.","volume":"52","author":"Warnes","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R34-20250324","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1093\/eurheartj\/ehq249","article-title":"ESC guidelines for the management of grown-up congenital heart disease (new version 2010).","volume":"31","author":"Baumgartner","year":"2010","journal-title":"Eur Heart J"},{"key":"R35-20250324","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s11886-009-0043-7","article-title":"Choosing the best contraceptive method for the adult with congenital heart disease.","volume":"11","author":"Silversides","year":"2009","journal-title":"Curr Cardiol Rep"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CRD.0000000000000905","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:21:54Z","timestamp":1786040514000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/CRD.0000000000000905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,24]]},"references-count":35,"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000000905","relation":{},"ISSN":["1538-4683"],"issn-type":[{"value":"1538-4683","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,24]]}}}